IRIS
CELLERINO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.635
AS - Asia 1.026
NA - Nord America 1.002
Continente sconosciuto - Info sul continente non disponibili 189
SA - Sud America 82
AF - Africa 22
OC - Oceania 3
Totale 6.959
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.497
US - Stati Uniti d'America 936
SG - Singapore 357
CN - Cina 259
VN - Vietnam 158
BD - Bangladesh 149
BR - Brasile 49
FR - Francia 34
CA - Canada 30
HK - Hong Kong 30
DE - Germania 19
FI - Finlandia 18
GB - Regno Unito 15
AR - Argentina 14
IN - India 13
NL - Olanda 13
MX - Messico 12
IQ - Iraq 11
JP - Giappone 10
PK - Pakistan 9
VE - Venezuela 8
RU - Federazione Russa 7
EC - Ecuador 6
JM - Giamaica 6
MA - Marocco 6
PH - Filippine 6
PL - Polonia 6
TN - Tunisia 5
TR - Turchia 5
ZA - Sudafrica 5
ID - Indonesia 4
UA - Ucraina 4
CH - Svizzera 3
CO - Colombia 3
ES - Italia 3
GT - Guatemala 3
JO - Giordania 3
NI - Nicaragua 3
SV - El Salvador 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
GR - Grecia 2
HT - Haiti 2
IE - Irlanda 2
KE - Kenya 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BW - Botswana 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PY - Paraguay 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.772
Salva come PNG Salva come JPEG
Città #
Genoa 2.358
Genova 911
Vado Ligure 615
Rapallo 389
San Jose 203
Singapore 185
Ashburn 165
Beijing 64
Ho Chi Minh City 61
New York 47
Milan 35
Council Bluffs 30
Hong Kong 30
Lauterbourg 29
Rome 26
Hanoi 25
Los Angeles 21
Santa Clara 19
Boardman 17
Helsinki 17
Turin 17
Frankfurt am Main 16
Chicago 13
Dallas 12
Bordighera 11
Buffalo 11
Naples 11
St Louis 11
Da Nang 10
Haiphong 9
Mexico City 8
Montreal 8
Tokyo 8
Orem 7
Philadelphia 7
Atlanta 6
Gainesville 6
Toronto 6
London 5
McCaskill 5
Aurora 4
Biên Hòa 4
Bologna 4
Cardiff 4
Cincinnati 4
Houston 4
Miami 4
Ninh Bình 4
Paris 4
Porto Alegre 4
São Paulo 4
Tampa 4
Trento 4
Valenza 4
Albuquerque 3
Amman 3
Baghdad 3
Boston 3
Can Tho 3
Caracas 3
Casablanca 3
Charlotte 3
Cleveland 3
Curitiba 3
Detroit 3
Florence 3
Guatemala City 3
Hải Dương 3
Johannesburg 3
Karbala 3
Kingston 3
Louisville 3
Managua 3
Phoenix 3
Quảng Ngãi 3
Rotterdam 3
San Francisco 3
San Salvador 3
Shenzhen 3
Thái Bình 3
Washington 3
Winchester 3
Acalanes Ridge 2
Amsterdam 2
Arlington 2
Baku 2
Belgrade 2
Bensalem 2
Brasília 2
Brescia 2
Bình Phước 2
Cagliari 2
Catania 2
Changsha 2
Chennai 2
Citrus Heights 2
City of London 2
Columbus 2
Corona 2
Corryton 2
Totale 5.610
Salva come PNG Salva come JPEG
Nome #
Different MRI patterns in MS worsening after stopping fingolimod 207
Osteopathic Manipulative Therapy and Multiple Sclerosis: A Proof-of-Concept Study 206
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 189
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 185
Levodopa-induced neutropenia. 176
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 169
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? 165
Corneal epithelial dendritic cells in patients with multiple sclerosis: An in vivo confocal microscopy study 164
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 156
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 147
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 145
Homonymous hemianopia as the first sign of posterior cortical atrophy 143
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 141
Assessing upper limb function in Multiple Sclerosis by an engineered glove 134
Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients 132
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 132
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 128
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 126
Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesions 126
On the Assessment of Gray Code Kernels for Motion Characterization in People with Multiple Sclerosis: A Preliminary Study 124
Clinical and radiological correlates of apathy in multiple sclerosis 120
Multiscale networks in multiple sclerosis 118
Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy Study 116
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 115
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis 114
Corneal sub-basal nerve plexus analysis in patients with multiple sclerosis 114
EXPLORING THE INTERACTION BETWEEN FOCAL INFLAMMATION AND AXONAL INJURY IN MULTIPLE SCELROSIS: A NEW MECHANISM-DRIVEN FRAMEWORK TO MONITOR DISEASE ACTIVITY AND PROGRESSION 113
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 112
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study 111
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 105
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 99
Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 99
Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: A case series 99
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 98
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 98
Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study 97
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 97
The effect of Cladribine and Fingolimod treatments on retinal atrophy 95
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 95
What happens after fingolimod discontinuation? A multicentre real-life experience 94
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 88
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 87
Predicting disease severity in Multiple Sclerosis using multimodal data and machine learning 80
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 80
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis 78
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 78
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 78
Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 76
The role of disconnection in explaining disability in multiple sclerosis 74
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 70
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 64
Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis 62
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 61
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study 59
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 56
Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience 55
Relationship between ovarian reserve and disease activity in women with multiple sclerosis 55
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 52
ELEVATED RISK OF THROMBOTIC MANIFESTATIONS OF SARS-COV-2 INFECTION IN CANCER PATIENTS: A LITERATURE REVIEW 50
Assessing Optic Nerve Involvement in Multiple SclerosisUsing Optical Coherence Tomography and Magnetic Resonance Imaging 47
The “central vein sign” to differentiate multiple sclerosis frommigraine 45
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis 42
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice 40
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 40
Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores 40
Childhood and Adolescent Environmental Risk Factors for Multiple Sclerosis: A Systematic Review With Meta-Analysis 36
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 32
First demyelinating attack in children: A twelve year single center cohort 30
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study 30
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis 24
null 20
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study 16
Functional and effective connectivity disruptions of the dopaminergic reward circuit in multiple sclerosis patients with depression 6
Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation 4
Totale 6.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.828
article - articoli 24.647
book - libri 0
conference - conferenze 531
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 327
Totale 51.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022253 9 4 5 21 13 19 4 55 24 41 9 49
2022/2023469 34 44 11 51 52 62 4 33 77 4 77 20
2023/2024556 20 42 16 58 34 66 156 24 24 26 30 60
2024/20251.597 87 105 64 102 208 163 163 264 97 73 139 132
2025/20263.077 335 134 180 237 356 164 362 182 264 288 226 349
2026/2027280 280 0 0 0 0 0 0 0 0 0 0 0
Totale 6.959